Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07279467 · ClinicalTrials.gov registry record
Study of Oral Food Challenge Biomarkers (SAFER)
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Not yet
- Registry status
- 500
- Enrollment target
NCT07279467 is a clinical trial that has not yet begun recruiting, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 500 participants.
The verdict
NCT07279467 has not yet begun recruiting, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- NOT YET RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
This is a multi-center, mechanistic study. It is designed to learn more about signs in the body, called biomarkers, that might show if someone will have a reaction to peanut during a feeding test. The trial will enroll children ages 12 months to17 years old who are suspected of having an allergy to peanut. The primary objective is to identify a biomarker (or a combination of biomarkers) that will predict oral food challenge (OFC) (feeding test) results for participants with suspected peanut allergy.
Interventions
- DRUG Oral Food Challenge (OFC): Peanut Protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07279467
The ClinicalTrials.gov registry entry for NCT07279467 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Food Challenge (OFC): Peanut Protein is the first listed.
NCT07279467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07279467 about?
NCT07279467 is a clinical study titled "Study of Oral Food Challenge Biomarkers (SAFER)". This is a multi-center, mechanistic study. It is designed to learn more about signs in the body, called biomarkers, that might show if someone will have a reaction to peanut during a feeding test. The trial will enroll children ages 12 months to17 years old who are suspected of having an allergy to ...
What is the current status of trial NCT07279467?
This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2026-04. Estimated completion is 2027-10-01.
What interventions are being tested in trial NCT07279467?
The interventions under investigation include: Oral Food Challenge (OFC): Peanut Protein (DRUG).
Who is sponsoring clinical trial NCT07279467?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.